BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9281375)

  • 1. A central segment of the NG2 proteoglycan is critical for the ability of glioma cells to bind and migrate toward type VI collagen.
    Burg MA; Nishiyama A; Stallcup WB
    Exp Cell Res; 1997 Aug; 235(1):254-64. PubMed ID: 9281375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NG2 proteoglycan mediates beta1 integrin-independent cell adhesion and spreading on collagen VI.
    Tillet E; Gential B; Garrone R; Stallcup WB
    J Cell Biochem; 2002; 86(4):726-36. PubMed ID: 12210739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and functional characterization of two type VI collagen receptors, alpha 3 beta 1 integrin and NG2, during avian corneal stromal development.
    Doane KJ; Howell SJ; Birk DE
    Invest Ophthalmol Vis Sci; 1998 Feb; 39(2):263-75. PubMed ID: 9477982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of NG2 proteoglycan causes retention of type VI collagen on the cell surface.
    Nishiyama A; Stallcup WB
    Mol Biol Cell; 1993 Nov; 4(11):1097-108. PubMed ID: 8305732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of truncated forms of the NG2 proteoglycan by cell surface proteolysis.
    Nishiyama A; Lin XH; Stallcup WB
    Mol Biol Cell; 1995 Dec; 6(12):1819-32. PubMed ID: 8590808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular basis of interaction between NG2 proteoglycan and galectin-3.
    Wen Y; Makagiansar IT; Fukushi J; Liu FT; Fukuda MN; Stallcup WB
    J Cell Biochem; 2006 May; 98(1):115-27. PubMed ID: 16365873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The membrane-spanning proteoglycan NG2 binds to collagens V and VI through the central nonglobular domain of its core protein.
    Tillet E; Ruggiero F; Nishiyama A; Stallcup WB
    J Biol Chem; 1997 Apr; 272(16):10769-76. PubMed ID: 9099729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of NG2 proteoglycan in the human intervertebral disc.
    Akeda K; An HS; Pichika R; Patel K; Muehleman C; Nakagawa K; Uchida A; Masuda K
    Spine (Phila Pa 1976); 2007 Feb; 32(3):306-14. PubMed ID: 17268261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The NG2 chondroitin sulfate proteoglycan: a multifunctional proteoglycan associated with immature cells.
    Levine JM; Nishiyama A
    Perspect Dev Neurobiol; 1996; 3(4):245-59. PubMed ID: 9117258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the NG2 proteoglycan enhances the growth and metastatic properties of melanoma cells.
    Burg MA; Grako KA; Stallcup WB
    J Cell Physiol; 1998 Nov; 177(2):299-312. PubMed ID: 9766527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NG2/HMPG modulation of human articular chondrocyte adhesion to type VI collagen is lost in osteoarthritis.
    Midwood KS; Salter DM
    J Pathol; 2001 Dec; 195(5):631-5. PubMed ID: 11745701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of the NG2 proteoglycan to type VI collagen and other extracellular matrix molecules.
    Burg MA; Tillet E; Timpl R; Stallcup WB
    J Biol Chem; 1996 Oct; 271(42):26110-6. PubMed ID: 8824254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NG2 proteoglycan-binding peptides target tumor neovasculature.
    Burg MA; Pasqualini R; Arap W; Ruoslahti E; Stallcup WB
    Cancer Res; 1999 Jun; 59(12):2869-74. PubMed ID: 10383148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Collagen VI-NG2 axis in human tendon fibroblasts under conditions mimicking injury response.
    Sardone F; Santi S; Tagliavini F; Traina F; Merlini L; Squarzoni S; Cescon M; Wagener R; Maraldi NM; Bonaldo P; Faldini C; Sabatelli P
    Matrix Biol; 2016 Sep; 55():90-105. PubMed ID: 26944560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NG2 proteoglycan increases mesangial cell proliferation and extracellular matrix production.
    Xiong J; Wang Y; Zhu Z; Liu J; Wang Y; Zhang C; Hammes HP; Lang F; Feng Y
    Biochem Biophys Res Commun; 2007 Oct; 361(4):960-7. PubMed ID: 17686464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testican 2 abrogates inhibition of membrane-type matrix metalloproteinases by other testican family proteins.
    Nakada M; Miyamori H; Yamashita J; Sato H
    Cancer Res; 2003 Jun; 63(12):3364-9. PubMed ID: 12810672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NG2-expressing cells in the nervous system: role of the proteoglycan in migration and glial-neuron interaction.
    Karram K; Chatterjee N; Trotter J
    J Anat; 2005 Dec; 207(6):735-44. PubMed ID: 16367801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two separate metalloproteinase activities are responsible for the shedding and processing of the NG2 proteoglycan in vitro.
    Asher RA; Morgenstern DA; Properzi F; Nishiyama A; Levine JM; Fawcett JW
    Mol Cell Neurosci; 2005 May; 29(1):82-96. PubMed ID: 15866049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remodeling of collagen matrix by human tumor cells requires activation and cell surface association of matrix metalloproteinase-2.
    Deryugina EI; Bourdon MA; Reisfeld RA; Strongin A
    Cancer Res; 1998 Aug; 58(16):3743-50. PubMed ID: 9721888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NG2/CSPG4-collagen type VI interplays putatively involved in the microenvironmental control of tumour engraftment and local expansion.
    Cattaruzza S; Nicolosi PA; Braghetta P; Pazzaglia L; Benassi MS; Picci P; Lacrima K; Zanocco D; Rizzo E; Stallcup WB; Colombatti A; Perris R
    J Mol Cell Biol; 2013 Jun; 5(3):176-93. PubMed ID: 23559515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.